MedisimVR raises Rs 3.5cr in pre-series A round led by IP Ventures

The funds raised by MedisimVR will be used by the company for scaling up its product offering and adding more skill training content to their library

coronavirus, drugs, medicine, pharma, vaccine, research
(Photo: Bloomberg)
BS Reporter Mumbai
2 min read Last Updated : Mar 24 2022 | 12:44 PM IST
MedisimVR, a med-tech company, has raised Rs 3.5 crore in a Pre-Series A round led by Inflection Point Ventures. The round also saw participation from Chennai Angels and Jana Balasubramaniam (MedTech investor). The funds raised will be used by the company for scaling up its product offering and adding more skill training content to their library.

MediSimVR aims to make comprehensive medical training accessible & affordable across the world through their current offerings which include procedural simulation, virtual patient simulation and clinical education. They have been able to onboard almost 500 medical students in the last 4 months.

Vinay Bansal, founder & CEO, Inflection Point Ventures, said, “As we enter the 3rd of the pandemic, the benefits of technology and use cases have also changed with the evolution of the health tech landscape. MediSimVR has understood this need for the healthcare industry to move one notch higher and adapt to new age training technology for skilling medical students and healthcare professionals alike. Their simulation skill training programme is where one can actually practice surgical training, encounter virtual patients scenarios, evaluate the learning metrics which will help the medical fraternity immensely.”

The key product offered by MediSimVR is the virtual reality-based skill training platform, that covers all the skills required in the MBBS curriculum. Some of the other features include performance analytics & evaluation metrics to better assess the learning pattern and competency.

Sabarish Chandrasekaran, co-founder & CEO, MedisimVR, says, “The future healthcare workforce of India needs a futuristic training methodology and an alignment among visionary entities for rapid scaling up. At MediSimVR, we are excited to partner with IPV as we embark on this journey of change.”

The Global VR healthcare market is valued at $3.8 billion and projected to reach $30.40 billion by 2026. The market potential is huge, MediSimVR is aiming to facilitate medical students to learn, practice & hone their skills in a more accurate environment. MediSimVR marries the benefits of Virtual reality and Haptics and elevates healthcare training to a new dimension.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Pharmamed-tech firmsSeries A funding

Next Story